Crestor (Rosuvastatin) (Crestor 20 mg) and Ribociclib: interaction and safety
This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.
Interaction mechanism
Laboratory evidence suggests transporter inhibition could increase the partner medicine’s exposure.
Clinical significance and safety
With Crestor (Rosuvastatin) and Ribociclib, monitor tolerability and use the clinical or laboratory checks appropriate to the partner medicine. This is a mechanistic possibility based on in-vitro transporter studies; it is not proof that every patient develops toxicity or that the combination is automatically contraindicated. The treatment team should assess whether any adjustment is needed.
Using this information
This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.